[go: up one dir, main page]

MX7235E - Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune - Google Patents

Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune

Info

Publication number
MX7235E
MX7235E MX8210226U MX1022682U MX7235E MX 7235 E MX7235 E MX 7235E MX 8210226 U MX8210226 U MX 8210226U MX 1022682 U MX1022682 U MX 1022682U MX 7235 E MX7235 E MX 7235E
Authority
MX
Mexico
Prior art keywords
immune serum
preparing
serum globulin
procedure
injectable solution
Prior art date
Application number
MX8210226U
Other languages
English (en)
Inventor
Robert A Tenold
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of MX7235E publication Critical patent/MX7235E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX8210226U 1981-08-24 1982-08-05 Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune MX7235E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/295,916 US4396608A (en) 1981-08-24 1981-08-24 Intravenously injectable immune serum globulin

Publications (1)

Publication Number Publication Date
MX7235E true MX7235E (es) 1988-01-26

Family

ID=23139776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8210226U MX7235E (es) 1981-08-24 1982-08-05 Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune

Country Status (9)

Country Link
US (1) US4396608A (es)
EP (1) EP0073371B1 (es)
JP (2) JPH0694421B2 (es)
AT (1) ATE16567T1 (es)
AU (1) AU549204B2 (es)
CA (1) CA1183084A (es)
DE (1) DE3267593D1 (es)
ES (1) ES8306440A1 (es)
MX (1) MX7235E (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
JPH08787B2 (ja) * 1982-08-30 1996-01-10 バクスター、インターナショナル、インコーポレイテッド ガンマグロブリン含有組成物の製造法
WO1984001505A1 (en) * 1982-10-21 1984-04-26 Minneapolis Med Res Opsonins in peritoneal dialysis
AT383737B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur verwendung einer immunoglobulin-g enthaltenden fraktion
DK166763C (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
US4719290A (en) * 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
US5161472A (en) * 1984-03-30 1992-11-10 Handy Barry L Multi-function draft implement
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4659563A (en) * 1986-01-27 1987-04-21 Miles Laboratories, Inc. High titer anti-respiratory syncytial virus intravenous immune globulin
US5159064A (en) * 1986-04-08 1992-10-27 Miles Inc. Preparation of virus-free antibodies
US4948877A (en) * 1986-04-08 1990-08-14 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
US5419906A (en) * 1986-04-08 1995-05-30 Miles Inc. Preparation of human immunoglobulin free of hepatitis C
US4762714A (en) * 1986-04-08 1988-08-09 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
JPH07103045B2 (ja) * 1986-07-09 1995-11-08 株式会社ミドリ十字 非化学修飾γ−グロブリンの加熱処理方法
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
EP0417191B1 (en) * 1988-05-27 1993-03-10 Centocor, Inc. Formulation for antibody reagents
EP0417193B1 (en) * 1988-05-27 1993-08-04 Centocor, Inc. Freeze-dried formulation for antibody products
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
US5847086A (en) * 1991-06-20 1998-12-08 Centeon L.L.C. Therapeutic fragments of von Willebrand factor
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
US6096216A (en) * 1994-06-09 2000-08-01 American National Red Cross Iodinated matrices for disinfecting biological fluids
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6686191B1 (en) * 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin
AU1705197A (en) * 1996-01-19 1997-08-11 Eli Lilly And Company Obesity protein formulations
AU2243997A (en) * 1996-01-19 1997-08-11 Eli Lilly And Company Obesity protein formulations
RU2122864C1 (ru) * 1996-12-26 1998-12-10 Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского Препарат иммуноглобулина для внутривенного введения и способ его получения
TW541179B (en) * 1997-03-19 2003-07-11 Green Cross Corp Process for preparing immunoglobulin preparation
WO1998044948A2 (en) * 1997-04-07 1998-10-15 Cangene Corporation Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
US6955917B2 (en) * 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
RU2140289C1 (ru) * 1998-01-30 1999-10-27 Государственное унитарное предприятие "Иммунопрепарат" Способ получения внутривенного иммуноглобулина
US6106773A (en) * 1998-09-24 2000-08-22 American National Red Cross Pathogen inactivating compositions for disinfecting biological fluids
AU2003211991B2 (en) * 2002-02-14 2008-08-21 Chugai Seiyaku Kabushiki Kaisha Antibody-containing solution formulations
US20040022792A1 (en) * 2002-06-17 2004-02-05 Ralph Klinke Method of stabilizing proteins at low pH
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
EP1909831A4 (en) 2005-06-14 2013-02-20 Amgen Inc SELF-BUFFING PROTEIN FORMULATIONS
KR20090069330A (ko) * 2006-10-12 2009-06-30 와이어쓰 유백광/응집체를 감소시키기 위한 항체 용액 중의 이온 강도의 변화
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
CA2721037C (en) 2008-04-15 2018-05-22 Talecris Biotherapeutics, Inc. Methods for preparing a concentrated plasma product formulation using ultrafiltration/diafiltration
EP2477603B1 (en) 2009-09-17 2016-03-30 Baxalta Incorporated Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
KR101912169B1 (ko) 2010-02-04 2018-10-26 체에스엘 베링 아게 면역글로불린 제제
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
ES2381828B1 (es) 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
AU2015357068B2 (en) 2014-12-03 2021-07-29 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins
KR102446838B1 (ko) 2016-10-21 2022-09-26 암젠 인크 약학적 제형 및 그의 제조 방법
WO2019157340A1 (en) * 2018-02-08 2019-08-15 Amgen Inc. Low ph pharmaceutical antibody formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
EP0498006A1 (en) * 1991-02-06 1992-08-12 International Business Machines Corporation Superheterodyning technique in the spatial frequency domain and structure for pattern registration measurement
JPH07238036A (ja) * 1994-02-28 1995-09-12 Green Cross Corp:The 静注用グロブリン液状組成物のグロブリン二量体増加抑制方法

Also Published As

Publication number Publication date
JPH05208918A (ja) 1993-08-20
ES515177A0 (es) 1983-06-01
EP0073371B1 (en) 1985-11-21
ATE16567T1 (de) 1985-12-15
JPH0694421B2 (ja) 1994-11-24
EP0073371A2 (en) 1983-03-09
EP0073371A3 (en) 1983-09-21
JPS5843914A (ja) 1983-03-14
US4396608A (en) 1983-08-02
AU549204B2 (en) 1986-01-16
CA1183084A (en) 1985-02-26
JPH0761956B2 (ja) 1995-07-05
ES8306440A1 (es) 1983-06-01
DE3267593D1 (en) 1986-01-02
AU8726582A (en) 1983-03-03

Similar Documents

Publication Publication Date Title
MX7235E (es) Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune
ATE74766T1 (de) Verfahren zur herstellung von antikoerperzusammensetzungen von therapeutischen mitteln mit verlaengerter serumhalbwertzeit.
DE2962569D1 (en) Immune serum globulin preparations and method to produce them
BG43866A3 (en) Method for preparing of derivatives of 2, 2'- imino- bis- ethanol
DE3486030D1 (de) Monoklonale antikoerper, spezifisch von in vivo von fibrinogen abgeleiteten derivatstuecken.
DE3064888D1 (en) Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
NL930133I2 (nl) Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
EP0216454A3 (en) Method of promoting animal growth
BG42004A3 (en) Method for preparing pyridyl compounds
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
SE7904161L (sv) Komposition for minskning av fenylalaninnivan i blod och anvendning derav
FR2513122B1 (es)
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI832919A7 (fi) Menetelmä N-substituoidun nikotiiniamidi-1-oksidin ja sen suolojen valmistamiseksi.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
ES8505642A1 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
EP0265238A3 (en) Composition for treating rheumatoid arthritis
DK499583D0 (da) Fremgangsmade til fremstilling af en isoquinolinforbindelse
ES8404183A1 (es) Un procedimiento para la preparacion de composiciones farmaceuticas orales de acido propionhidroxamico.